Thermal Capsulorrhaphy Policy
Defines coverage position for thermal capsulorrhaphy (thermal capsular shrinkage) for treatment of joint instability (shoulder, knee, elbow, others) for Medicare Advantage and commercial plans administered by BCBSRI.
Policy states thermal capsulorrhaphy is not covered / not medically necessary due to insufficient evidence and potential for harm.
Coverage Summary
Thermal capsulorrhaphy (thermal capsular shrinkage) is considered not covered / not medically necessary for the treatment of joint instability because the evidence is insufficient to demonstrate an improvement in net health outcome. This position applies to the shoulder (the primary joint studied) and to other joints proposed for the procedure, including the knee, elbow, and others.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.